Cargando…
A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism
The social motivation hypothesis of autism posits that autism spectrum disorder (ASD) is characterized by impaired motivation to seek out social experience early in life that interferes with the development of social functioning. This framework suggests that impaired mesolimbic dopamine function und...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801430/ https://www.ncbi.nlm.nih.gov/pubmed/33431841 http://dx.doi.org/10.1038/s41398-020-01170-0 |
_version_ | 1783635573125152768 |
---|---|
author | Zürcher, Nicole R. Walsh, Erin C. Phillips, Rachel D. Cernasov, Paul M. Tseng, Chieh-En J. Dharanikota, Ayarah Smith, Eric Li, Zibo Kinard, Jessica L. Bizzell, Joshua C. Greene, Rachel K. Dillon, Daniel Pizzagalli, Diego A. Izquierdo-Garcia, David Truong, Kinh Lalush, David Hooker, Jacob M. Dichter, Gabriel S. |
author_facet | Zürcher, Nicole R. Walsh, Erin C. Phillips, Rachel D. Cernasov, Paul M. Tseng, Chieh-En J. Dharanikota, Ayarah Smith, Eric Li, Zibo Kinard, Jessica L. Bizzell, Joshua C. Greene, Rachel K. Dillon, Daniel Pizzagalli, Diego A. Izquierdo-Garcia, David Truong, Kinh Lalush, David Hooker, Jacob M. Dichter, Gabriel S. |
author_sort | Zürcher, Nicole R. |
collection | PubMed |
description | The social motivation hypothesis of autism posits that autism spectrum disorder (ASD) is characterized by impaired motivation to seek out social experience early in life that interferes with the development of social functioning. This framework suggests that impaired mesolimbic dopamine function underlies compromised responses to social rewards in ASD. Although this hypothesis is supported by functional magnetic resonance imaging (fMRI) studies, no molecular imaging study has evaluated striatal dopamine functioning in response to rewards in ASD. Here, we examined striatal functioning during monetary incentive processing in ASD and controls using simultaneous positron emission tomography (PET) and fMRI. Using a bolus + infusion protocol with the D2/D3 dopamine receptor antagonist [(11)C]raclopride, voxel-wise binding potential (BP(ND)) was compared between groups (controls = 12, ASD = 10) in the striatum. Striatal clusters showing significant between-group BP(ND) differences were used as seeds in whole-brain fMRI general functional connectivity analyses. Relative to controls, the ASD group demonstrated decreased phasic dopamine release to incentives in the bilateral putamen and left caudate, as well as increased functional connectivity between a PET-derived right putamen seed and the precuneus and insula. Within the ASD group, decreased phasic dopamine release in the putamen was related to poorer theory-of-mind skills. Our findings that ASD is characterized by impaired striatal phasic dopamine release to incentives provide support for the social motivation hypothesis of autism. PET-fMRI may be a suitable tool to evaluate novel ASD therapeutics targeting the striatal dopamine system. |
format | Online Article Text |
id | pubmed-7801430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-78014302021-01-21 A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism Zürcher, Nicole R. Walsh, Erin C. Phillips, Rachel D. Cernasov, Paul M. Tseng, Chieh-En J. Dharanikota, Ayarah Smith, Eric Li, Zibo Kinard, Jessica L. Bizzell, Joshua C. Greene, Rachel K. Dillon, Daniel Pizzagalli, Diego A. Izquierdo-Garcia, David Truong, Kinh Lalush, David Hooker, Jacob M. Dichter, Gabriel S. Transl Psychiatry Article The social motivation hypothesis of autism posits that autism spectrum disorder (ASD) is characterized by impaired motivation to seek out social experience early in life that interferes with the development of social functioning. This framework suggests that impaired mesolimbic dopamine function underlies compromised responses to social rewards in ASD. Although this hypothesis is supported by functional magnetic resonance imaging (fMRI) studies, no molecular imaging study has evaluated striatal dopamine functioning in response to rewards in ASD. Here, we examined striatal functioning during monetary incentive processing in ASD and controls using simultaneous positron emission tomography (PET) and fMRI. Using a bolus + infusion protocol with the D2/D3 dopamine receptor antagonist [(11)C]raclopride, voxel-wise binding potential (BP(ND)) was compared between groups (controls = 12, ASD = 10) in the striatum. Striatal clusters showing significant between-group BP(ND) differences were used as seeds in whole-brain fMRI general functional connectivity analyses. Relative to controls, the ASD group demonstrated decreased phasic dopamine release to incentives in the bilateral putamen and left caudate, as well as increased functional connectivity between a PET-derived right putamen seed and the precuneus and insula. Within the ASD group, decreased phasic dopamine release in the putamen was related to poorer theory-of-mind skills. Our findings that ASD is characterized by impaired striatal phasic dopamine release to incentives provide support for the social motivation hypothesis of autism. PET-fMRI may be a suitable tool to evaluate novel ASD therapeutics targeting the striatal dopamine system. Nature Publishing Group UK 2021-01-11 /pmc/articles/PMC7801430/ /pubmed/33431841 http://dx.doi.org/10.1038/s41398-020-01170-0 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Zürcher, Nicole R. Walsh, Erin C. Phillips, Rachel D. Cernasov, Paul M. Tseng, Chieh-En J. Dharanikota, Ayarah Smith, Eric Li, Zibo Kinard, Jessica L. Bizzell, Joshua C. Greene, Rachel K. Dillon, Daniel Pizzagalli, Diego A. Izquierdo-Garcia, David Truong, Kinh Lalush, David Hooker, Jacob M. Dichter, Gabriel S. A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism |
title | A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism |
title_full | A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism |
title_fullStr | A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism |
title_full_unstemmed | A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism |
title_short | A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism |
title_sort | simultaneous [(11)c]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801430/ https://www.ncbi.nlm.nih.gov/pubmed/33431841 http://dx.doi.org/10.1038/s41398-020-01170-0 |
work_keys_str_mv | AT zurchernicoler asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT walsherinc asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT phillipsracheld asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT cernasovpaulm asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT tsengchiehenj asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT dharanikotaayarah asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT smitheric asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT lizibo asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT kinardjessical asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT bizzelljoshuac asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT greenerachelk asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT dillondaniel asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT pizzagallidiegoa asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT izquierdogarciadavid asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT truongkinh asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT lalushdavid asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT hookerjacobm asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT dichtergabriels asimultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT zurchernicoler simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT walsherinc simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT phillipsracheld simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT cernasovpaulm simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT tsengchiehenj simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT dharanikotaayarah simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT smitheric simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT lizibo simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT kinardjessical simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT bizzelljoshuac simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT greenerachelk simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT dillondaniel simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT pizzagallidiegoa simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT izquierdogarciadavid simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT truongkinh simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT lalushdavid simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT hookerjacobm simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism AT dichtergabriels simultaneous11craclopridepositronemissiontomographyandfunctionalmagneticresonanceimaginginvestigationofstriataldopaminebindinginautism |